A carregar...
Biomarkers in immunotherapy: literature review and future directions
Within the past decade, immunotherapy has revolutionized the treatment of advanced non-small lung cancer (NSCLC). Immune checkpoint inhibitors (ICIs) such as pembrolizumab, nivolumab, atezolizumab, and durvalumab have shown superiority over chemotherapy regimens in patients with programmed death-lig...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578474/ https://ncbi.nlm.nih.gov/pubmed/33145089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.15 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|